United States of America
Christopher Molineaux has served as a member of Aclaris Therapeutics’ board of directors since January 2014. Since 2009, Mr. Molineaux has served as President and Chief Executive Officer of Life Sciences Pennsylvania, a pharmaceutical and biotech industry advocacy organization. Prior to joining Life Sciences Pennsylvania, Mr. Molineaux served as Worldwide Vice President of Pharmaceutical Communication and Public Affairs for Johnson & Johnson. Mr. Molineaux previously served as Vice President for Public Affairs at the Pharmaceutical Research and Manufacturers Association (PhRMA) and held positions at the Federal Department of Health & Human Services and the White House. He holds a Bachelor of Arts from the College of the Holy Cross.
Host defense mechanisms,LPS effects on neurotransmitters